Paolo Mascagni

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

Flavio Leoni, Andrea Zaliani, Giorgio Bertolini et al. · Proceedings of the National Academy of Sciences · 2002 · 500 citations · Full text

Chemoprevention Strategy, Immunology, Cell Death +18

The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo

Flavio Leoni, Gianluca Fossati, Eli C. Lewis et al. · Molecular Medicine · 2005 · 324 citations · Full text

Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice

Rainer Glauben, Arvind Batra, I Fedke et al. · The Journal of Immunology · 2006 · 291 citations · Full text

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Pavan Reddy, Yaping Sun, Tomomi Toubai et al. · Journal of Clinical Investigation · 2008 · 267 citations · Full text

Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain

Giuseppe Faraco, Tristano Pancani, Laura Formentini et al. · Molecular Pharmacology · 2006 · 254 citations